CN Bio Innovations Ltd.

“We’re at an exciting juncture in medicine where the perceived scientific boundaries in treatment across therapeutic areas continue to dissolve.” These words from Jeffrey Jones , chief medical office

“I’m optimistic when it comes to both the integration and the impact of transformative technologies across the life sciences industry,” said Jessica Federer , Bayer ’s former chief digital officer a

If you ask those involved, you may be led to believe that the use of organs on chips (OOCs) for drug development will become mainstream within the next couple of years. And there is some evidence to s